Volume 12 Issue 6
Nov.  2021
Turn off MathJax
Article Contents
LIU Xiao, YANG Nan, WU Shouyuan, GUO Qiangqiang, LIU Hui, SUN Yajia, WANG Jianjian, ZHOU Qi, WANG Zijun, SHI Qianling, ZHAO Siya, LI Qinyuan, LUO Xufei, LYU Meng, SONG Xuping, CHEN Yaolong. Investigation and Evaluation of Chinese Clinical Practice Guidelines Published in Medical Journals in 2019: Analysis of the Evidence[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 1016-1021. doi: 10.12290/xhyxzz.2021-0624
Citation: LIU Xiao, YANG Nan, WU Shouyuan, GUO Qiangqiang, LIU Hui, SUN Yajia, WANG Jianjian, ZHOU Qi, WANG Zijun, SHI Qianling, ZHAO Siya, LI Qinyuan, LUO Xufei, LYU Meng, SONG Xuping, CHEN Yaolong. Investigation and Evaluation of Chinese Clinical Practice Guidelines Published in Medical Journals in 2019: Analysis of the Evidence[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 1016-1021. doi: 10.12290/xhyxzz.2021-0624

Investigation and Evaluation of Chinese Clinical Practice Guidelines Published in Medical Journals in 2019: Analysis of the Evidence

doi: 10.12290/xhyxzz.2021-0624
Funds:

National Social Science Fund of China 19ZDA142

National Key Research and Development Program of China 2018YFC1705500

Fundamental Research Funds for the Central Universities lzujbky-2021-ey13

More Information
  • Corresponding author: SONG Xuping  Tel: 86-931-8912639, E-mail: songxp@lzu.edu.cn; CHEN Yaolong  Tel: 86-931-8912639, E-mail: chenyaolong@vip.163.com
  • Received Date: 2021-08-31
  • Accepted Date: 2021-11-11
  • Publish Date: 2021-11-30
  •   Objective  To investigate the current status of evidence of recommendations contained in Chinese clinical practice guidelines published in journals in 2019, so as to provide reference for the use of evidence for Chinese guidelines in the future.  Methods  We searched and analyzed information on Chinese guidelines published in 2019 with clear recommendations, grading of evidence quality and corresponding instructions of grading, as well as information on citations supporting the recommendations.  Results  A total of 31 guidelines (29 Chinese guidelines and 2 English guidelines) containing 568 recommendations and 3126 references were included. Each guideline included an average of 18 recommendations. Of these, 2541 references were presented as evidence in the statements of guideline recommendation(such references are referred to as "evidence" hereafter). The average number of evidence was 82 in each guideline and every recommendation has 4 pieces of evidence. The top three countries where the evidence was from were China (28.8%), the United States (25.9%), and the United Kingdom (7.0%). Only 39.2% (995/2541) of the evidence was published in the last 5 years. The most common type of evidence for guidelines was randomized controlled trials (26.9%). The citation of systematic reviews was only 12.0%.  Conclusions  Most of the Chinese guidelines published in 2019 did not have clear and unambiguous recommendations. Those guidelines with clear recommendations had incomplete and untimely evidence citations. Guideline developers should strengthen the rational use of currently available research evidence.
  • loading
  • [1] Institute of Medicine. Clinical practice guidelines we can trust[M]. Washington (DC): the National Academies Press, 2011.
    [2] Djulbegovic B, Guyatt GH. Progress in evidence-based medicine: a quarter century on[J]. Lancet, 2017, 390: 415-423. doi:  10.1016/S0140-6736(16)31592-6
    [3] World Health Organization. WHO Handbook for guideline development, 2nd Edition[M/OL]. (2014-12-18)[2021-08-31]. https://www.who.int/publications/i/item/9789241548960.
    [4] Scottish Intercollegiate Guidelines Network. SIGN 50: A guideline developers' handbook[M/OL]. (2019-11)[2021-08-31]. https://www.sign.ac.uk/our-guidelines/sign-50-a-guideline-developers-handbook/.
    [5] National Institute for Health and Clinical Excellence. The Guidelines Manual: Process and Methods[EB/OL]. (2012-11-30)[2021-08-31]. https://www.nice.org.uk/process/pmg6/resources/the-guidelines-manual-pdf-2007970804933.
    [6] 陈耀龙, 元博, 孙丽娜, 等. 中国临床实践指南引文分析[J]. 中国循证儿科杂志, 2013, 8: 467-470. https://www.cnki.com.cn/Article/CJFDTOTAL-XZEK201306021.htm

    Chen YL, Yuan B, Sun LN, et al. Citation analysis of Chinese clinical practice guidelines[J]. Zhongguo Xunzheng Erke Zazhi, 2013, 8: 467-470. https://www.cnki.com.cn/Article/CJFDTOTAL-XZEK201306021.htm
    [7] Chen YL, Wang C, Shang HC, et al. Clinical practice guidelines in China[J]. BMJ, 2018, 360: j5158. http://oldmed.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_ssekzz201805002
    [8] 杨楠, 陈耀龙. 2019年期刊公开发表的中国临床实践指南现状评价[J]. 协和医学杂志, 2021, 12: 407-410. doi:  10.12290/xhyxzz.2021-0323

    Yang N, Chen YL. Evaluation of Chinese Clinical Practice Guidelines Published in Medical Journals in 2019[J]. Xiehe Yixue Zazhi, 2021, 12: 407-410. doi:  10.12290/xhyxzz.2021-0323
    [9] 王子君, 史乾灵, 刘云兰, 等. 2019年期刊公开发表的中国临床实践指南文献调查与评价—制订人员及工作组情况[J]. 协和医学杂志, 2021, 12: 552-559. doi:  10.12290/xhyxzz.2021-0438

    Wang ZJ, Shi QL, Liu YL, et al. Investigation and Evaluation of Chinese Clinical Practice Guidelines Published in Medical Journals in 2019: Status of the Authorship and Guideline Development Group[J]. Xiehe Yixue Zazhi, 2021, 12: 552-559. doi:  10.12290/xhyxzz.2021-0438
    [10] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国脑血管病一级预防指南2019[J]. 中华神经科杂志, 2019, 52: 684-709. doi:  10.3760/cma.j.issn.1006-7876.2019.09.002

    Chinese Society of Neurology, Chinese Stroke Society. Guidelines for the primary prevention of cerebrovascular diseases in China 2019[J]. Zhonghua Shenjingke Zazhi, 2019, 52: 684-709. doi:  10.3760/cma.j.issn.1006-7876.2019.09.002
    [11] Grant J, Cottrell R, Cluzeau F, et al. Evaluating"payback"on biomedical research from papers cited in clinical guidelines: appliedbibliometric study[J]. BMJ, 2000, 320: 1107-1111. doi:  10.1136/bmj.320.7242.1107
    [12] 刘淼, 吕筠, 李立明. 循证指南引文分析在医学研究产出评价中的应用[J]. 中国循证医学杂志, 2011, 11: 1090-1093.

    Liu M, Lyu J, Li LM. Application of evidence-based guideline reference analysis in the evaluation of medical research outputs[M]. Zhongguo Xunzheng Yixue Zazhi, 2011, 11: 1090-1093.
    [13] Chen YL, Yang KH, Marušic A, et al. A Reporting Tool for Practice Guidelines in Health Care: The RIGHT State-ment[J]. Ann Intern Med, 2016, 166: 128-132. http://ueaeprints.uea.ac.uk/61475/1/RIGHT_statement_manuscript_SEP_23.pdf
    [14] Brouwers MC, Kho ME, Browman GP, et al. AGREE Ⅱ: advancing guideline development, reporting and evaluation in health care[J]. CMAJ, 2010, 182: E839-E842. http://www.sciencedirect.com/science/article/pii/S0895435610002477
    [15] Woodhead M. 80% of China's clinical trial data are fraudulent, investigation finds[J]. BMJ, 2016, 355: i5396. http://www.onacademic.com/detail/journal_1000039676183310_ed1d.html
    [16] 李楠, 姚亮, 王琪, 等. 中国临床实践指南证据检索策略报告情况调查[J]. 中国循证医学杂志, 2014, 14: 1510-1513. doi:  10.7507/1672-2531.20140241

    Li N, Yao L, Wang Q, et al. Survey on the Reporting of Evidence Search Strategies in Clinical Practice Guidelines in China[J]. Zhongguo Xunzheng Yixue Zazhi, 2014, 14: 1510-1513. doi:  10.7507/1672-2531.20140241
    [17] 王小钦, 王吉耀. 循证临床实践指南的制定与实施[M]. 北京: 人民卫生出版社, 2016.
    [18] 李秉严, 李彭元, 喻志刚. 信息检索与利用·医学[M]. 成都: 四川科学技术出版社, 2003.
    [19] Shekelle PG. Clinical Practice Guidelines: What's Next?[J]. JAMA, 2018, 320: 757-758. doi:  10.1001/jama.2018.9660
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(2)

    Article Metrics

    Article views (474) PDF downloads(127) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return